Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents

Diabetic patients remain at increased risk for mortality after revascularization with early generation DES during long-term follow-up. Conversely, diabetes is no longer associated with an increased risk of clinical and angiographic restenosis after revascularization with early generation DES.